Prognosis of left-sided infective endocarditis in patients transferred to a tertiary-care hospital-prospective analysis of referral bias and influence of inadequate antimicrobial treatment

Clinical Microbiology and Infection

Volumn 17, Issue 5, 2011, Pages 769-775

  Fernandez Hidalgo N ^a   Almirante, B ^a   Tornos, P ^a   Gonzalez Alujas M T ^a   Planes, A M ^a   Larrosa, M N ^a   Sambola, A ^a   Igual, A ^b   Pahissa, A ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Inappropriate treatment; Infective endocarditis; Mortality; Prognosis; Referral bias

Indexed keywords

BETA LACTAM ANTIBIOTIC; GENTAMICIN; STREPTOMYCIN; TEICOPLANIN; TOBRAMYCIN;

ADULT; AGED; ARTICLE; BACTERIAL ENDOCARDITIS; COHORT ANALYSIS; DIAGNOSTIC ACCURACY; DRUG TREATMENT FAILURE; FEMALE; HUMAN; INAPPROPRIATE PRESCRIBING; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PATIENT REFERRAL; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; SPAIN; TERTIARY HEALTH CARE;

EID: 79955365136     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03314.x     Document Type: Article

References (21)

1. Tleyjeh IM, Abdel-Latif A, Rahbi H et al. A systematic review of population-based studies of infective endocarditis. Chest 2007; 132: 1025-1035.
2. López-Dupla M, Hernández S, Olona M et al. Clinical characteristics and outcome of infective endocarditis in individuals of the general population managed at a teaching hospital without cardiac surgery facilities: study of 120 cases. Rev Esp Cardiol 2006; 59: 1131-1139.
3. Wang A, Athan E, Pappas PA et al. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA 2007; 297: 1354-1361.
4. Thuny F, Avierinos JF, Tribouilloy C et al. Impact of cerebrovascular complications on mortality and neurologic outcome during infective endocarditis: a prospective multicentre study. Eur Heart J 2007; 28: 1155-1161.
5. Murdoch DR, Corey GR, Hoen B et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century. The International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 2009; 169: 463-473.
6. Baddour LM, Wilson WR, Bayer AS et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Disease Society of America. Circulation 2005; 111: 394-434.
7. Habib G, Hoen B, Tornos P et al. Guidelines on prevention, diagnosis and treatment of infective endocarditis (new version 2009). The task force on the prevention, diagnosis, and treatment of infective endocarditis of the European Society of Cardiology. Eur Heart J 2009; 30: 2369-2413.
8. Vallés F, Anguita M, Escribano MP et al. Practice guidelines of the Spanish society of cardiology on endocarditis. Rev Esp Cardiol 2000; 53: 1384-1396.
9. Prendergast BD. The changing face of infective endocarditis. Heart 2006; 92: 879-885.
10. Fernández-Hidalgo N, Almirante B, Tornos P et al. Contemporary epidemiology and prognosis of health care-associated infective endocarditis. Clin Infect Dis 2008; 47: 1287-1297.
11. Benito N, Miró JM, de Lazzari E et al. Health care-associated native valve endocarditis: importante of non-nosocomial acquisition. Ann Intern Med 2009; 150: 586-594.
12. Steckelberg JM, Melton LJ 3rd, Ilstrup DM, Rouse MS, Wilson WR. Influence of referral bias on the apparent clinical spectrum of infective endocarditis. Am J Med 1990; 88: 582-588.
13. Delahaye F, Rial MO, de Gevigney G, Ecochard R, Delaye J. A critical appraisal of the quality of the management of infective endocarditis. J Am Coll Cardiol 1999; 33: 788-793.
14. Li JS, Sexton DJ, Mick N et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2002; 30: 633-638.
15. Kanafani Z, Boucher H, Fowler V et al. Daptomycin compared to standard therapy for the treatment of native valve endocarditis. Enferm Infecc Microbiol Clin 2010; doi.
16. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 1994; 11: 1245-1251.
17. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999; 16: 9-13.
18. Gálvez-Acebal J, Rodríguez-Baño J, Martínez-Marcos FJ et al. Prognostic factors in left-sided endocarditis: results from the Andalusian multicenter cohort. BMC Infect Dis 2010; 10: 17-24.
19. Gavaldà J, Len O, Miró JM et al. Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone. Ann Intern Med 2007; 146: 574-579.
20. Botelho-Nevers E, Thuny F, Casalta JP et al. Dramatic reduction in infective endocarditis-related mortality with a management-based approach. Arch Intern Med 2009; 169: 1290-1298.
21. Tattevin P, Donal E, Revest M. Can we really achieve a 1-year mortality rate lower than 10% in patients with infective endocarditis? Arch Intern Med 2010; 170: 211.